Table 1.
Characteristics | Number of cases (%) |
---|---|
Sex | |
Male | 56 (75.7) |
Female | 18 (24.3) |
Age (years) | |
≤60 | 40 (54.1) |
>60 | 34 (45.9) |
ECOG scale | |
0 and 1 scores | 70 (94.6) |
2 score | 4 (5.4) |
History of hepatitis B | |
Yes | 62 (83.8) |
No | 12 (16.2) |
BCLC staging | |
0 | 15 (20.3) |
A | 59 (79.7) |
Prior TACE | |
Yes | 12 (16.2) |
No | 62 (83.8) |
GTV (mL) | |
≤7.5 | 14 (18.9) |
>7.5 | 60 (81.1) |
Total liver volume (mL) | |
≤1,162 | 25 (33.8) |
>1,162 | 49 (66.2) |
Normal liver volume (mL) | |
≤1,148 | 29 (39.2) |
>1,148 | 45 (60.8) |
Number of lesions | |
1 | 67 (90.5) |
>1 | 7 (9.5) |
Intrahepatic progression | |
Yes | 12 (16.2) |
No | 62 (83.8) |
Abbreviations: BCLC, Barcelona Clinic Liver Cancer; ECOG, Eastern Cooperative Oncology Group; GTV, gross tumor volume; HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization.